Let them sell. Shareholders with millions of shares are not selling. The company is worth hundreds of millions, if not billions with the contract. I'm staying for the NOLs & IPs, or the lawsuit against the incompetent monitor if it comes to that. It's a no brainer.
Screen capture attached below so that it doesn't get "lost."
What this guy seems to be overlooking is a contract that might generate revenue will also have costs of manufacturing. BioAmber used all the contracts they had and were not making a profit. While there might be $600M of potential revenue, the contract is worthless if there isn't profit. That's why nobody wanted the blooming contracts when they were offered in the SISP, when the liquidation happened (the JV could have had them for a song), and haven't wanted them since.
The NOL's really are worthless. You have to continue operations in order to use them, and BioAmber really has no operations, haven't since they were severed in the bankruptcy liquidation.
If there were value in either of them, the creditors would be all over the monitor and judge to try and realize it. No, really, they have good lawyers and accountants and would have been filing motions since the proceedings began if they saw additional recovery potential.
News 
Market Data 
Discover 
